drugset / Trial / NCT00232284

Treatment of Comorbid Depression and Substance Abuse in Young People

NCT00232284

Phase 2 Completed 60 enrolled Dan Lubman
RandomizedSingle-groupDouble-blindTreatment

Summary

This study aims to treat young people with an adjunctive integrated cognitive behavioral therapy (CBT) intervention and to examine the acceptability of this treatment approach within this population. The study will also include a pilot placebo-controlled trial of sertraline for those young people who fail to or only partially respond to the CBT intervention, so as to determine whether adjunctive anti-depressant treatment improves clinical response in this population.

Timeline

Start
2004-09
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sertraline Small molecule 50 mg
Comparator Sertraline Small molecule 100 mg